Full-Time
Cardiac Surgeon
Main Line Health
51-200 employees
Biomedical research division advancing cancer science
No salary listed
Ardmore, PA, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
- Completed an approved fellowship program and certified by the American Board of Thoracic Surgery (ABTS) or foreign equivalent
- Eligible for medical licensure in the State of Pennsylvania
- Early and mid-career surgeons with focused interest on complex coronary revascularization (CABG) and VAD surgery are encouraged to apply
- Experience in on-pump, off-pump, and multi-arterial CABG is required
- Experience in Robotic CABG and MID-CABG approaches is preferred but not required. Senior mentorship can be provided by renowned CABG surgeon, Dr. Francis Sutter
- Proven ability to collaborate and effectively communicate within an interdisciplinary team and with referring physicians to provide high-quality patient care
- Communicate regularly and effectively with families and patients regarding plan of care
- Demonstrate orientation toward providing evidence-based, patient-centered care, quality and process improvement, and team building
- Possess proven leadership skills, outstanding verbal and written communication skills; experience with EMR is a significant plus
- Maintain confidentiality in all aspects of the job
- Perform other related duties as assigned
- Working with the cardiac surgical and cardiology teams to maintain and grow the cardiac surgical program with a focus on Heart failure/Ventricular Assist Device (VAD) program, advanced coronary revascularization techniques including on/off-pump CABG, multi-arterial grafting, robotic/MID-CABG and hybrid CABG/PCI options
- Provide coverage of the cardiac surgery service and perform general cardiothoracic procedures and on-call duties
- Robotic CABG and MID-CABG approaches are preferred but not required (already listed under requirements as preferred)
- Senior mentorship can be provided by renowned CABG surgeon, Dr. Francis Sutter (already in requirements)
- Experience with EMR is a significant plus (listed in requirements as part)
Lankenau Institute for Medical Research (LIMR) is the research division of Main Line Health that conducts cancer and biomedical research and translates basic science into clinical applications. LIMR studies cell growth and cancer biology, develops discoveries in the lab, and collaborates to move findings into patient care within the health system. It differs from other research centers by its long history as one of the first U.S. cancer-focused institutes, its integration within a hospital-based health system, and its track record of translational research—turning lab findings into clinical therapies and practices. The institute aims to improve patient outcomes by turning basic science into usable medical treatments and interventions for cancer and related diseases.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Lancaster, Pennsylvania
Founded
1927
Simplify's Take
What believers are saying
- LIMR leads immunotherapy revolution with SYNC-T cryoimmune prostate cancer trial.
- Main Line Health runs over 35 clinical trials from LIMR innovations.
- Sharpe-Strumia Foundation bridges LIMR lab discoveries to clinical practice.
What critics are saying
- Funding cuts halt LIMR IP development and spinouts within 12-24 months.
- Fox Chase secures 40% more pharma partnerships, diverting LIMR collaborators.
- SYNC-T trial failure terminates lead program in 18-24 months.
What makes Main Line Health unique
- LIMR pioneered cancer research in 1927 by studying it as cell growth problem.
- LIMR discovered Philadelphia chromosome in 1960, launching cancer genetics.
- LIMR employs ACAPRENEURIAL™ model integrating invention, IP, and spinouts.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Main Line Health who can refer or advise you
Benefits
Pension
403(b) Retirement Plan
Unlimited Paid Time Off
Tuition Reimbursement
Wellness Program
Family Planning Benefits
Company News
PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform with health systems and providers in its network to streamline data exchange, close gaps in care, and improve health outcomes for members. Epic Payer Platform is part of Epic, a global healthcare technology company. The platform helps facilitate data exchange and workflow processes for providers and health plans, giving them the insights they need to make care decisions while also saving them time. "We're excited about the implementation of Epic Payer Platform with Drexel Medicine, Jefferson Health, Main Line Health, and Penn Medicine being the first to join us in this transformation. We look forward to more of our health care partners signing on as well," said Michael Vennera, executive vice president and chief strategy, technology, and operations officer at Independence Blue Cross
When George Prendergast was appointed president and CEO of the Lankenau Institute of Medical Research (LIMR) in 2004, he coined the term “acapreneurial” as a mashup for the model he wanted to implement — inventions and startup incubation alongside traditional academic goals of research, new knowledge and its validation.